MK0476 phase III open label exploratory comparative clinical study -acute exacerbations of asthma.

Trial Profile

MK0476 phase III open label exploratory comparative clinical study -acute exacerbations of asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Montelukast (Primary) ; Aminophylline
  • Indications Acute asthma
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 21 Jul 2009 Actual patient numbers amended from 90 to 91 as reported by ClinicalTrials.gov.
    • 11 Aug 2008 Actual study completion date (1 Aug 2007) added as reported by ClinicalTrials.gov.
    • 11 Aug 2008 Actual number of patients is now 90 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top